Evidence map›Paper›PMID 37151218›Full record

ArticleRevista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia2023

Inhibitory Effects and Related Molecular Mechanisms of Huanglian-Ganjiang Combination Against H1N1 Influenza Virus.

Yao Sun, Cheng-Ling Yu, Yun-Liang Yan, Feng-Ling Zhang, Jing Chen, Zi-Yi Hu, Jia He, Xiong-Yu Meng, Qiao-Feng Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yao SunSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-8625-5770
Cheng-Ling YuSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-5382-1190
Yun-Liang YanSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-8021-6092
Feng-Ling ZhangSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-6417-8372
Jing ChenSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0001-8697-3265
Zi-Yi HuSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0003-1726-7417
Jia HeNo. 903 Hospital of PLA Joint Logistic Support Force, Hangzhou, China.ORCID 0000-0001-6397-7335
Xiong-Yu MengSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0003-0794-1308
Qiao-Feng WuSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-9690-4092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza is an infectious acute respiratory disease with complications and a high mortality rate; the effective medicines for influenza therapy are limited. "Huanglian" or Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s43450-023-00372-z.

Indexed as

Anti-H1N1 influenzaAutophagyBerberineGingerolPneumoniaTLR/RLR signaling

Identifiers

PMID37151218
PMCPMC9994783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.